Hiraga A, Cohen P
Eur J Biochem. 1986 Dec 15;161(3):763-9. doi: 10.1111/j.1432-1033.1986.tb10505.x.
The glycogen-bound form of protein phosphatase-1 (termed protein phosphatase-1G) is composed of the catalytic (C) subunit complexed to a glycogen-binding (G) subunit that anchors the enzyme to glycogen [Strålfors et al. (1985) Eur. J. Biochem. 149, 295-303]. Incubation of purified protein phosphatase-1G with cyclic-AMP-dependent protein kinase and MgATP, which leads to stoichiometric phosphorylation of the G-subunit [Caudwell et al. (1986) FEBS Lett. 194, 85-90], was found to promote the release of the phosphatase from glycogen; similar observations were made using glycogen-protein particle preparations. An intravenous injection of adrenaline decreased protein phosphatase-1 activity associated with the glycogen-protein particles by 50% with a corresponding increase in the amount present in the cytosol. By contrast, adrenaline did not affect the distribution of glycogen synthase or glycogen phosphorylase which remained entirely bound to glycogen in these experiments. The specific release of protein phosphatase-1 from glycogen may facilitate its inactivation by inhibitor-1 in the cytosol, thereby preventing dephosphorylation of the glycogen metabolising enzymes. Translocation of protein phosphatase-1 may represent a novel mechanism for the activation of glycogenolysis and inhibition of glycogen synthesis by adrenaline.
与糖原结合的蛋白磷酸酶-1(称为蛋白磷酸酶-1G)由催化(C)亚基与糖原结合(G)亚基复合而成,该亚基将酶锚定在糖原上[斯特拉尔福斯等人(1985年),《欧洲生物化学杂志》149卷,295 - 303页]。将纯化的蛋白磷酸酶-1G与环磷酸腺苷依赖性蛋白激酶和MgATP一起孵育,这会导致G亚基发生化学计量的磷酸化[考德威尔等人(1986年),《欧洲生物化学学会联合会快报》194卷,85 - 90页],结果发现这会促进磷酸酶从糖原上释放;使用糖原 - 蛋白质颗粒制剂也得到了类似的观察结果。静脉注射肾上腺素会使与糖原 - 蛋白质颗粒相关的蛋白磷酸酶-1活性降低50%,同时胞质溶胶中该酶的含量相应增加。相比之下,肾上腺素并不影响糖原合酶或糖原磷酸化酶的分布,在这些实验中它们仍完全与糖原结合。蛋白磷酸酶-1从糖原上的特异性释放可能有助于其在胞质溶胶中被抑制剂-1灭活,从而防止糖原代谢酶的去磷酸化。蛋白磷酸酶-1的易位可能代表了肾上腺素激活糖原分解和抑制糖原合成的一种新机制。